前收市價 | 51.40 |
開市 | 51.40 |
買盤 | 33.40 |
賣出價 | 37.50 |
拍板 | 560.00 |
到期日 | 2025-01-17 |
今日波幅 | 51.40 - 51.40 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 29 |
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
McKesson Corporation (NYSE:MCK) Q4 2024 Earnings Call Transcript May 7, 2024 McKesson Corporation misses on earnings expectations. Reported EPS is $6.18 EPS, expectations were $6.36. McKesson Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Please stand by. Welcome to […]
MCK earnings call for the period ending March 31, 2024.